Reports on the struggle of the National Institutes of Health's (NIH) Recombinant DNA Advisory Committee (RAC) with the underlying issue of whether to put safety or science first when reviewing proposed gene studies. Leanings of the RAC members toward safety during the June 1995 meeting; NIH director Harold Varmus' opinion on the issue; Set up of review panels; Mission discussions.